These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3102804)

  • 21. The antihypertensive effect of taurine in DOCA-salt rats.
    Fujita T; Sato Y
    J Hypertens Suppl; 1984 Dec; 2(3):S563-5. PubMed ID: 6152784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased basal and reactive plasma norepinephrine and epinephrine levels in awake DOCA-salt hypertensive rats.
    Bouvier M; de Champlain J
    J Auton Nerv Syst; 1986 Feb; 15(2):191-5. PubMed ID: 3958436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the adrenal medullae in male and female DOCA-salt hypertensive rats.
    Lange DL; Haywood JR; Hinojosa-Laborde C
    Hypertension; 1998 Jan; 31(1 Pt 2):403-8. PubMed ID: 9453336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Kuro T; Okahara A; Nose M; Ikuse T; Matsumura Y
    Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS; Turgeon A; Schiffrin EL
    Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A comparative study of C19 steroid-induced hypertension and deoxycorticosterone acetate (DOCA)-salt hypertension].
    Minato M; Honda M; Hatano M
    Nihon Naibunpi Gakkai Zasshi; 1990 Jan; 66(1):29-41. PubMed ID: 2307256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in blood pressure and extracellular fluid with taurine in DOCA-salt rats.
    Fujita T; Sato Y
    Am J Physiol; 1986 Jun; 250(6 Pt 2):R1014-20. PubMed ID: 3717374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of sympathetic nervous system in hypotensive action of taurine in DOCA-salt rats.
    Sato Y; Ando K; Fujita T
    Hypertension; 1987 Jan; 9(1):81-7. PubMed ID: 2878880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of supplemental dietary calcium on the development of DOCA-salt hypertension in weanling rats.
    Perry PA
    West J Nurs Res; 1995 Feb; 17(1):63-75; discussion 101-11. PubMed ID: 7863648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Carboxamidotryptamine attenuates the development of deoxycorticosterone acetate-salt hypertension in rats.
    Balasubramaniam G; Lee HS; Mah SC
    Eur J Pharmacol; 1995 Mar; 276(1-2):183-90. PubMed ID: 7781688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of manidipine on cardiac hypertrophy and coronary circulation in DOCA/salt hypertensive rats.
    Takeda K; Nakata T; Kuwabara T; Itoh H; Yamahara Y; Takesako T; Tanabe S; Sasaki S; Asayama J; Nakagawa M
    Blood Press Suppl; 1992; 3():48-52. PubMed ID: 1343289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of intraventricular and intraspinal 6-hydroxydopamine on blood pressure of DOCA-saline hypertensive rats.
    Kubo T; Hashimoto M
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):50-9. PubMed ID: 485704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase in the hypotensive effect of bromocriptine induced by spinal transection in rats: contribution of spinal dopamine receptors.
    Lahlou S; Demenge P
    J Cardiovasc Pharmacol; 1992 May; 19(5):723-31. PubMed ID: 1381770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
    Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of renal sympathetic activity with potassium supplement in DOCA-salt rats.
    Sato Y; Fujita T
    Jpn Heart J; 1984 Mar; 25(2):253-61. PubMed ID: 6748225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypotensive action of taurine in DOCA-salt rats--involvement of sympathoadrenal inhibition and endogenous opiate.
    Sato Y; Ogata E; Fujita T
    Jpn Circ J; 1991 May; 55(5):500-8. PubMed ID: 2062001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic treatment with anti-endothelin antibodies fails to modify the development of hypertension in stroke-prone spontaneously hypertensive rats and DOCA-salt hypertensive rats.
    Yasujima M; Kanazawa M; Yoshida K; Kohzuki M; Watanabe H; Hiwatari M; Sato T; Abe K; Hirata Y; Yoshinaga K
    Tohoku J Exp Med; 1993 Jan; 169(1):43-50. PubMed ID: 8211968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central attenuation of aortic baroreceptor reflex in prehypertensive DOCA-salt-loaded rats.
    Nakamura Y; Takeda K; Nakata T; Hayashi J; Kawasaki S; Lee LC; Sasaki S; Nakagawa M; Ijichi H
    Hypertension; 1988 Sep; 12(3):259-66. PubMed ID: 3169941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiologic responses to chronic dietary tyrosine supplementation in DOCA-salt-treated rats.
    Henley WN; Fregly MJ; Wilson KM; Hathaway S
    Pharmacology; 1986; 33(6):334-47. PubMed ID: 3031700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.